Plasma microRNA biomarkers for detection of mild cognitive impairment
暂无分享,去创建一个
[1] Axel Benner,et al. Circulating microRNAs in plasma as early detection markers for breast cancer , 2013, International journal of cancer.
[2] D. V. Vactor,et al. MicroRNAs Shape the Neuronal Landscape , 2012, Neuron.
[3] F. Slack,et al. Novel MicroRNAs Differentially Expressed during Aging in the Mouse Brain , 2012, PloS one.
[4] A. Adai,et al. miRNA Biomarkers in Cyst Fluid Augment the Diagnosis and Management of Pancreatic Cysts , 2012, Clinical Cancer Research.
[5] Michael F. Ochs,et al. Serum microRNA Biomarkers for Detection of Non-Small Cell Lung Cancer , 2012, PloS one.
[6] A. Dejean,et al. Senescence is an endogenous trigger for microRNA-directed transcriptional gene silencing in human cells , 2012, Nature Cell Biology.
[7] L. Goff,et al. Expression profiling of synaptic microRNAs from the adult rat brain identifies regional differences and seizure-induced dynamic modulation , 2012, Brain Research.
[8] F. Slack,et al. MicroRNAs and their roles in aging , 2012, Journal of Cell Science.
[9] A. Budovsky,et al. Molecular links between cellular senescence, longevity and age-related diseases – a systems biology perspective , 2011, Aging.
[10] E. Wang,et al. Circulatory miR-34a as an RNA-based, noninvasive biomarker for brain aging , 2011, Aging.
[11] B. Schmand,et al. Value of Neuropsychological Tests, Neuroimaging, and Biomarkers for Diagnosing Alzheimer's Disease in Younger and Older Age Cohorts , 2011, Journal of the American Geriatrics Society.
[12] A. Fagan,et al. Comparison of analytical platforms for cerebrospinal fluid measures of β-amyloid 1-42, total tau, and p-tau181 for identifying Alzheimer disease amyloid plaque pathology. , 2011, Archives of neurology.
[13] R. Nagele,et al. Diagnosis of Parkinson's Disease Based on Disease-Specific Autoantibody Profiles in Human Sera , 2011, PloS one.
[14] R. Nagele,et al. Diagnosis of Alzheimer's Disease Based on Disease-Specific Autoantibody Profiles in Human Sera , 2011, PloS one.
[15] C. Luis,et al. Feasibility of Predicting MCI/AD Using Neuropsychological Tests and Serum β-Amyloid , 2011, International journal of Alzheimer's disease.
[16] Nick C Fox,et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[17] Denise C. Park,et al. Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[18] J. Morris,et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[19] A. Nakamura,et al. Identification of Muscle-Specific MicroRNAs in Serum of Muscular Dystrophy Animal Models: Promising Novel Blood-Based Markers for Muscular Dystrophy , 2011, PloS one.
[20] G. Schratt. microRNAs at the synapse , 2011, Nature Reviews Cancer.
[21] J O Rinne,et al. Amyloid PET imaging in patients with mild cognitive impairment , 2011, Neurology.
[22] A. Brunet,et al. The microRNA cluster miR-106b~25 regulates adult neural stem/progenitor cell proliferation and neuronal differentiation , 2011, Aging.
[23] D. DiMaio,et al. MicroRNAs and senescence , 2011, Aging.
[24] D. German,et al. Identification of Candidate IgG Biomarkers for Alzheimer's Disease via Combinatorial Library Screening , 2011, Cell.
[25] Eric Lai,et al. MicroRNA-Related Cofilin Abnormality in Alzheimer's Disease , 2010, PloS one.
[26] David A Loewenstein,et al. Assessing the progression of mild cognitive impairment to Alzheimer's disease: current trends and future directions , 2010, Alzheimer's Research & Therapy.
[27] J. Trojanowski,et al. Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people. , 2010, Archives of neurology.
[28] S. Moebus,et al. Prevalence of mild cognitive impairment and its subtypes in the Heinz Nixdorf Recall study cohort , 2010, Alzheimer's & Dementia.
[29] D. Alkon,et al. Early diagnostic accuracy and pathophysiologic relevance of an autopsy-confirmed Alzheimer's disease peripheral biomarker , 2010, Neurobiology of Aging.
[30] Amity E. Green,et al. 3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI , 2010, Human brain mapping.
[31] E. Masliah,et al. Molecular mechanisms of neurodegeneration in Alzheimer's disease. , 2010, Human molecular genetics.
[32] P. Provost,et al. Interpretation and applicability of microRNA data to the context of Alzheimer's and age-related diseases , 2010, Aging.
[33] Wenyaw Chan,et al. Predicting progression of Alzheimer's disease , 2010, Alzheimer's Research & Therapy.
[34] Yi Li,et al. Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies , 2009, Journal of clinical neurology.
[35] Greg Miller,et al. Alzheimer's biomarker initiative hits its stride. , 2009, Science.
[36] Duolao Wang,et al. Serum Aβ Levels as Predictors of Conversion to Mild Cognitive Impairment/Alzheimer Disease in an ADAPT Subcohort , 2009, Molecular medicine.
[37] Carole Dufouil,et al. Beyond mild cognitive impairment: vascular cognitive impairment, no dementia (VCIND) , 2009, Alzheimer's Research & Therapy.
[38] D. Bredesen. Neurodegeneration in Alzheimer's disease: caspases and synaptic element interdependence , 2009, Molecular Neurodegeneration.
[39] Lu Xie,et al. Identification and target prediction of miRNAs specifically expressed in rat neural tissue , 2009, BMC Genomics.
[40] D. Bartel. MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.
[41] Daniel B. Martin,et al. Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.
[42] John O. Willis,et al. Wechsler Adult Intelligence Scale–Third Edition , 2008 .
[43] Vetle I. Torvik,et al. Expression of microRNAs and their precursors in synaptic fractions of adult mouse forebrain , 2008, Journal of neurochemistry.
[44] T. Luck,et al. [Mild cognitive impairment and development of dementia]. , 2008, Psychiatrische Praxis.
[45] Heidi J. Peltier,et al. Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. , 2008, RNA.
[46] Yuriy Gusev,et al. Systematic evaluation of microRNA processing patterns in tissues, cell lines, and tumors. , 2007, RNA.
[47] R. Tibshirani,et al. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins , 2007, Nature Medicine.
[48] W. Chan,et al. Importance of Subtle Amnestic and Nonamnestic Deficits in Mild Cognitive Impairment: Prognosis and Conversion to Dementia , 2007, Dementia and Geriatric Cognitive Disorders.
[49] Sasha F. Levy,et al. Somatodendritic microRNAs identified by laser capture and multiplex RT-PCR. , 2007, RNA.
[50] C. Sander,et al. A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing , 2007, Cell.
[51] Yu Liang,et al. BMC Genomics , 2007 .
[52] Bin Zhang,et al. Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model , 2007, Neuron.
[53] Hwai-Jong Cheng,et al. Axon pruning: an essential step underlying the developmental plasticity of neuronal connections , 2006, Philosophical Transactions of the Royal Society B: Biological Sciences.
[54] E. Tangalos,et al. Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia. , 2006, Archives of neurology.
[55] Stijn van Dongen,et al. miRBase: microRNA sequences, targets and gene nomenclature , 2005, Nucleic Acids Res..
[56] C. Ko,et al. Pruning an Axon Piece by Piece A New Mode of Synapse Elimination , 2004, Neuron.
[57] Jeff W. Lichtman,et al. Axon Branch Removal at Developing Synapses by Axosome Shedding , 2004, Neuron.
[58] H. Amièva,et al. Incidence and outcome of mild cognitive impairment in a population-based prospective cohort , 2002, Neurology.
[59] J. Morris,et al. Current concepts in mild cognitive impairment. , 2001, Archives of neurology.
[60] N. Butters,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery , 1994, Neurology.
[61] J. Morris,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease , 1989, Neurology.
[62] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[63] D. O’Carroll,et al. General Principals of miRNA Biogenesis and Regulation in the Brain , 2013, Neuropsychopharmacology.
[64] J. Satoh. MicroRNAs and their therapeutic potential for human diseases: aberrant microRNA expression in Alzheimer's disease brains. , 2010, Journal of pharmacological sciences.
[65] W. Markesbery,et al. Neuropathologic alterations in mild cognitive impairment: a review. , 2010, Journal of Alzheimer's disease : JAD.
[66] V. Nimmrich,et al. Is Alzheimer's Disease a Result of Presynaptic Failure? - Synaptic Dysfunctions Induced by Oligomeric β-Amyloid , 2009, Reviews in the neurosciences.
[67] A. Roses,et al. Identification of miRNA Changes in Alzheimer's Disease Brain and CSF Yields Putative Biomarkers and Insights into Disease Pathways , 2008 .
[68] Patrizia Mecocci,et al. Mild cognitive impairment: a systematic review. , 2007, Journal of Alzheimer's disease : JAD.
[69] G. Davis,et al. Synapse disassembly. , 2003, Genes & development.
[70] E. Tangalos,et al. Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .
[71] Robert A. Bornstein,et al. The Wechsler Memory Scale—Revised , 1990 .
[72] C. Reynolds,et al. Wechsler memory scale-revised , 1988 .
[73] J. Eng,et al. Sample Size Estimation : How Many Individuals Should Be Studied ? , 2022 .